RG
ODT
Redmile Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,162
| Closed | -$338K | – | 94 |
|
|
2020
Q3 | $338K | Sell |
25,162
-607,876
| -96% | -$8.17M | 0.01% | 80 |
|
|
2020
Q2 | $26.8M | Sell |
633,038
-75,000
| -11% | -$3.18M | 0.49% | 53 |
|
|
2020
Q1 | $19.5M | Sell |
708,038
-82,033
| -10% | -$2.26M | 0.55% | 44 |
|
|
2019
Q4 | $25.6M | Buy |
790,071
+16,500
| +2% | +$535K | 0.61% | 44 |
|
|
2019
Q3 | $20.1M | Buy |
773,571
+32,900
| +4% | +$856K | 0.67% | 45 |
|
|
2019
Q2 | $27.2M | Buy |
740,671
+263,207
| +55% | +$9.66M | 0.77% | 40 |
|
|
2019
Q1 | $10.6M | Buy |
477,464
+20,513
| +4% | +$454K | 0.31% | 54 |
|
|
2018
Q4 | $6.43M | Sell |
456,951
-148,349
| -25% | -$2.09M | 0.26% | 58 |
|
|
2018
Q3 | $11.7M | Sell |
605,300
-5,300
| -0.9% | -$103K | 0.36% | 57 |
|
|
2018
Q2 | $13.5M | Buy |
610,600
+16,400
| +3% | +$362K | 0.46% | 49 |
|
|
2018
Q1 | $12.6M | Sell |
594,200
-2,700
| -0.5% | -$57.2K | 0.49% | 47 |
|
|
2017
Q4 | $14.9M | Buy |
+596,900
| New | +$14.9M | 0.65% | 46 |
|